Biliary Tract Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
Department of Medicine/Gastroenterology, University of Washington, Seattle, WA, USA
Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China
Department of Hepatology, University College London Institute for Liver and Digestive Health, London, UK
- » Bile acids and biliary disease
- » Bile duct tumors
- » Biliary tract infections
- » Endoscopic management of biliary tract disease
- » Fibropolycystic diseases of biliary tract
- » Gall bladder and biliary tract physiology
- » Gallstones: epidemiology, pathogenesis and treatment
- » Sclerosing cholangitis/benign biliary strictures
- » Sphincter of Oddi dysfunction
- » Surgical management of biliary tract disease
Patients with liver-predominant biliary tract cancer (BTC) are often pretreated and, despite this, continue to have an extremely poor survival. Owing to the lack of trials on regional chemotherapy in patients with advanced BTC, this...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
2 Recommendations, most recent by
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.